Background: Fibrinogen Matsumoto IV was found in a hypofibrinogenemia caused by a
Introduction
Fibrinogen is a 340 kDa plasma glycoprotein consisting of a dimeric molecule of 3 polypeptide chains Aα, Bβ, and γ, linked by an extensive network of 29 intrachain and interchain disulfide bonds [1] . Fibrinogen is synthesized in hepatocytes at plasma concentration of 1.8 -3.5 g/L. The chains are encoded by three genes, Aα, Bβ, and γ respectively, located in a cluster spanning some 50 kb on the long arm of chromosome 4 at 4q28-31 [2] . Each gene is separately transcribed and translated, and the nascent chains translocated into the endoplasmic reticulum (ER), where assembly occurs in a stepwise fashion [3] . Congenital hypo-and afibrinogenemia are associated with low and non-detectable levels of antigenic fibrinogen, respectively, and have been demonstrated in a variety of 54 cases mutations in all three genes, Aα-chain; 27, Bβ-chain; 14, γ-chain; 13 cases [4] , including missense, nonsense and frameshift mutations; splice-site abnormalities, and larger deletions [5, 6] . It has not been demonstrated clearly, however, what the molecular mechanisms might be by which one amino acid substitution caused by a missense mutation can lead to impaired assembly or secretion of the fibrinogen.
We have previously reported a hypofibrinogenemia caused by a heterozygous missense mutation, the substitution of the γ-chain residue Cys153 by Arg (Fibrinogen Matsumoto IV) [7] . To examine the molecular basis for this fibrinogen deficiency, the variant fibrinogens of γ153Arg and γ153Ala were expressed in Chinese hamster ovary (CHO) cells. Immunoblot and metabolic pulse-chase analyses indicated that CHO cells transfected with the γ153Arg-or γ153Ala-coding vector synthesized the variant chains, but did not assemble the variant fibrinogen and did not secrete it into culture medium [7] .
In a model of the processes involved in the assembly and biosynthesis of fibrinogen, Aα/γ and Bβ/γ dimers linked by a disulfide bonds are proposed to be intermediates which, upon addition of a third chain, form the Aα/Ββ/γ half-molecule and then mature fibrinogen (Aα/Ββ/γ)2 [8, 9] . Fibrinogen Matsumoto IV strongly suggests that the formation of the Aα/γ-and Bβ/γ-dimer is disturbed. Even though the Aα-, Ββ-, γ-chain are expressed together in CHO cells, it is a challenge to identify the components of the complexes, so we co-expressed each of two pair chains in the CHO cell lines, CHO-Aα/γ, -Aα/γm, -Bβ/γ, -Bβ/γm. In this report, we provide a molecular mechanism for inducing the impaired assembly of the intact γ153Ala fibrinogen.
Materials and Methods

Recombinant protein expression
For synthesis of the γ153Ala variant, the fibrinogen γ-chain expression vector, pMLPγ, was altered by oligonucleotide-directed mutagenesis as previously reported (γm-vector) [7] .
CHO cells were cotransfected with mixtures of any two of the vectors, i.e., the fibrinogen Aα-, Bβ-, γ-or γm-chains, along with a neomycine selection plasmid (pRSVneo), using the standard calcium-phosphate coprecipitation method. Individual cell lines were selected with a medium containing G418, and were examined for the expression of each polypeptide by means of immunoblot analysis under reducing conditions, and clones were established producing high as well as approximately equivalent levels of each of the two polypeptides, and were designated as CHO-Aα/Bβ, CHO-Aα/γ, CHO-Aα/γm, CHO-Bβ/γ, and CHO-Bβ/γm, respectively. In addition, a CHO cell line secreting intact fibrinogen, CHO-NC, was used as a control.
Immunoblot analysis
Cell lysates for immunoblot analysis were prepared as follows. After the individual cells were grown to confluence in 60-mm culture dishes, the media were removed and the cells were scraped into 100µL of non-reducing sample buffer for sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE). For the reducing conditions, 5% 2-mercaptoethanol (2ME) was added to the samples.
SDS-PAGE and immunoblot analyses for fibrinogen or individual polypeptides were
performed according to the methods of Laemmli [10] and Huang et al. [11] , respectively.
For two-dimensional electrophoresis (2-DE), the first-run was performed on an 8% gel under non-reducing conditions and the second-run was performed on a 10% gel under reducing conditions. Briefly, individual lanes were cut from the gel of the first-run, incubated for 30 minutes in Tris-HCl buffer (pH6.8) containing 5% 2ME for sample reduction, and laid on secondary gels and underwent a run of electrophoresis.
Immunoblots were developed with a rabbit anti-human fibrinogen antibody (DAKO, Carpinteria, CA), or a rabbit anti-human fibrinogen Aα-or Bβ-chain antibody (both from Chemicon International Inc., Temecula, CA), or anti-human fibrinogen γ-chain mouse monoclonal antibody 2G10 (Accurate Chemical & Scientific Corp. NY) [12] .
Cross-reacting species were visualized with horseradish peroxidase-conjugated goat antirabbit IgG or antimouse IgG antibody (Medical and Biological Laboratories, Nagoya, Japan) and enhanced chemiluminescence (ECL) detection reagents (Amersham Pharmacia Biotech, Buckinghamshire, UK). Blots were exposed on Hyperfilm-ECL (Amersham Pharmacia Biotech). (Fig.1B) . On the other hand, CHO-Aα/γm and CHO-Bβ/γm exhibited no apparent complexes (Fig.1B) .
Results
Expression
To identify the polypeptide constitution of the intermediates in fibrinogen assembly non-reducing SDS-PAGE and immunoblot analysis were performed using each of three polypeptide specific antibodies (Fig.1C-E) . With the antiAα-chain antibody, in CHO-Aα/γ, the 166 kDa band and Aα-chain were observed, but in CHO-Aα/γm, only the Aα-chain were observed (Fig.1C) . With the antiBβ-chain antibody, in CHO-Bβ/γ cells the 141 kDa band and Bβ-chain were observed, but in CHO-NC, -A/B and -Bβ/γm cells, two faint bands around 141 kDa and the Bβ-chain were observed (Fig.1D) . The two faint bands around 141 kDa remained indeterminate by analysis using each of three polypeptide specific antibodies and 2-DE. These observations indicate that no Aα/Bβ complex was to be found in not only the CHO-Aα/Bβ but also the CHO-NC cell line (Figs.1C and D) . Unfortunately, some of the undetermined, non-specific bands were observed when using the antiγ-chain monoclonal antibody (Fig.1E) . Therefore an effort was made to examine the complex formation using 2-DE ( Fig.2A-F) . Briefly, the complexes were first separated by SDS-PAGE under non-reducing conditions and then run on SDS-PAGE again in the presence of 2-ME.
In the CHO-NC cells, intact fibrinogen, Aα/Bβ/γ (280 kDa)-and Aα/γ (166kDa)-complexes, two types of Aα-oligomers (148 and 93 kDa), a Bβ-oligomer (118 kDa), and single Aα-, Bβ-, and γ-chains were observed on the 2-DE gel ( Fig.2A) . For the CHO-Aα/Bβ cells both the 166kDa band was composed only of the Aα-chain (Fig.2B ).
For the CHO-Aα/γ cells, the 166 kDa band was separated from the Aα-and γ-chains and the CHO-Bβ/γ cells, the 141 kDa band was separated from the Bβ-and γ-chains, respectively (Figs.2C and 2D). In contrast, for the CHO-Aα/γm the faint 170 kDa band was an Aα-oligomer and for the CHO-Bβ/γm no complex was observed (Figs. 2E and 2F). These results suggested that γm-chain is not able to assemble with the Aα-or Bβ-chains.
Discussion
To examine the precise basis for the fibrinogen deficiency, mixtures of any two vectors, the fibrinogen Aα-, Bβ-, γ-(153Cys) or γm-(153Ala) chain were transfected into CHO cells. The expression and constitution of each of the two chains and their complexes in the individual CHO cell lines were identified by immunoblot analysis using polypeptide specific antibodies and 2-DE.
In this report, evidence is provided which clearly demonstrates that the Aα/γ and Bβ/γ complexes, which are the assembly intermediates of fibrinogen, are formed in CHO-Aα/γ and CHO-Bβ/γ cells, respectively whereas γ153Ala did not form these complexes with the Aα-or Bβ-chain. These results reveal that the substitution of the γ-chain residue Cys153 by Ala completely impairs the assembly of fibrinogen in CHO cells as well as the subsequent secretion into medium, as has already reported [7] .
Two groups have examined and reported the process of fibrinogen assembly from three polypeptide chains in BHK or COS-1 cells [8, 13] . They demonstrated that the γ-chain is a key polypeptide for fibrinogen assembly. Briefly, in a first step, Aα/γ-and Bβ/γ-complexes are formed, and in the second step, these two are assembled into the Aα/Bβ/γ complex and finally into intact fibrinogen, (Aα/Bβ/γ)2. Interestingly, however, the Aα/Bβ-complex was not detected. Furthermore, Zhang JZ et al. [14] directly demonstrated that disruption of the disulfide loop of the γ-chain, γ153Cys-γ182Cys, resulted in the formation of fewer Aα/γ-and Bβ/γ-complexes and abolished fibrinogen assembly in COS-1 cells. Thus, the loss of Cys at residue 153 necessarily disrupts the disulfide bond between γ153C and γ182C, and the loss of the disulfide bond very likely induces profound changes in the overall structure of the C-terminal domain of the γ-chain. Our data demonstrate that the 153Ala mutation did not participate in assembly, and did not form intermolecular disulfide linked products with either the Aα-or Bβ-chains.
We have directly examined the role of the γ-chain by monitoring the synthesis of fibrinogen with increasing deletions from the C-terminus of the γ-chain. We found that residues near the C-terminus of the γ-chain were essential for fibrinogen assembly, and more specifically, that γIle387 was critical [15] . Crystal structures of this γ-chain domain show that γIle387 lies within a region of β-strand composed of the residues γ381-388, which inserts in an anti-parallel fashion between the strands formed by residues γ190-197 and γ244-251 [16, 17] . We propose that the loss of γIle387 markedly changes the 5-stranded anti-parallel β-strand sheet and thus the overall tertiary structure of γ-chain, preventing assembly αγ and βγ dimers. The recombinant 153Ala γ-chain is speculated to have a marked disruption of tertiary structure of the C-terminal domain because γ153Cys-γ182Cys is adjacent to β-strand of γ190-197.
Our data indicate that this disruption also leads to assembly of the variant chain into fibrinogen, consistent with the conclusion that the overall structure of this region has a unique role for the assembly of normal fibrinogen [15] .
Recently, hypo-or afibrinogenemia, which are caused by an amino acid substitution in the C-terminal domain of the γ-chain, have been reported in 4 cases, i.e., substitutions of γ284Gly by Arg [18] , γ345Asp by Asp [19] , γ371Thr by Ile [20] , γ375Arg by Trp [21] . Although all 4 cases are not determined in terms of the assembly of variant fibrinogen by ex vivo protein expression analysis, two cases, namely γ284Arg [18] and γ375Try [21] , are associated with hepatic ER storage disease. We speculate from our observation that in these cases the variant γ-chains were not assembled into variant fibrinogen. Interestingly, using transient transfection assays, Duga et al [22] , Vu et al [23] , and Spena et al [24] demonstrated that Bβ-chains with substitutions in the C-terminal region of the Bβ-chain, i.e., Bβ353Leu by Arg, Bβ400Gly by Asp,
Bβ414Gly by Ser, and Bβ437Trp by Gly, assembled into normal 6-chain fibrinogens, but were not secreted into media. These data suggest that the tertiary structure of Bβ-module may be critical to fibrinogen secretion but not assembly. These studies suggest that the tertiary structure of the γ-chain C-terminal domain is critical for fibrinogen assembly and the subsequent requisite secretion from hepatocytes.
Finally, the results presented here are completely in accord with the assembly process proposed in the above, and further reveal that the structure of the γ-chain C-terminal domain and/or γ153Cys per se is essential for fibrinogen assembly, in particular the formation of the Aα/γ-and Bβ/γ-complexes. This abnormality is demonstrated to be one of the molecular mechanisms leading to congenital hypo-and afibrinogenemia. 
